AMZN
Amazon.com, Inc.
AMZN has lower modeled downside risk, despite its lower overall score.
GLBE
Global-e Online Ltd.
GLBE has the edge over AMZN overall, supported by stronger fundamentals.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
GLBE Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Strong | |
| Strong |
GLBE's revenue, profitability, cash flow and balance sheet are all currently healthy.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
GLBE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 28x | $41.05 | — |
| Current | 47x | $41.05 | — |
| Cheap | 58x | $50.06 | +22% |
| Fair | 81x | $69.45 | +69% |
| Expensive | 1,044x | $898 | +2088% |
Historical ranges are pointers, not guarantees.
GLBE has the edge over AMZN in the historical PE scenario, which offers more potential upside but is not a forecast.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
GLBE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
GLBE has the edge over AMZN on the outlook, with more favorable valuation expectations.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN's earnings per share have climbed steadily: $12.37 over the past year, up 75% from the year before, and higher year over year for 14 quarters in a row. Its recent earnings include one-off gains.
GLBE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.48 | +72% |
| Q2 2026 | $0.86 | +$1.03 |
| Q1 2026 | $0.66 | +$1.02 |
| Q4 2025 | $0.38 | +$0.82 |
| Q3 2025 | $0.04 | +$0.62 |
| Q2 2025 | -$0.17 | +$0.48 |
| Q1 2025 | -$0.36 | +$0.38 |
| Q4 2024 | -$0.44 | +$0.37 |
| Q3 2024 | -$0.58 | +$0.28 |
GLBE has returned to profit: it earned $0.86 per share over the past year, after losing money the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN's revenue has grown year over year every quarter since late 2020: $202B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN's operating margin was 14% last quarter, up 4.2 points from the same quarter a year ago, near the top of its range since 2019.
GLBE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $299M | +39% |
| Q1 2026 | $252.1M | +33% |
| Q4 2025 | $336.7M | +28% |
| Q3 2025 | $220.8M | +25% |
| Q2 2025 | $214.9M | +28% |
| Q1 2025 | $189.9M | +30% |
| Q4 2024 | $262.9M | +42% |
| Q3 2024 | $176M | +32% |
GLBE has the edge over AMZN on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 15% | +10 points |
| Q1 2026 | 13% | +23 points |
| Q4 2025 | 19% | +17 points |
| Q3 2025 | 7.7% | +20 points |
| Q2 2025 | 4.9% | +19 points |
| Q1 2025 | -10% | +10 points |
| Q4 2024 | 2% | +14 points |
| Q3 2024 | -12% | +15 points |
GLBE has the edge over AMZN on profitability, with a higher operating margin.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
GLBE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $73.2M | +15% |
| Q1 2026 | -$72.9M | -$320K |
| Q4 2025 | $216.2M | +68% |
| Q3 2025 | $73.6M | +146% |
| Q2 2025 | $63.5M | 0% |
| Q1 2025 | -$72.6M | -$17.4M |
| Q4 2024 | $128.8M | +39% |
| Q3 2024 | $29.9M | +14% |
GLBE has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over GLBE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
GLBE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +1.1M shares |
| 1 year | +3.1% | +5.3M shares |
| 3 years | +6.6% | +10.9M shares |
| 5 years | +101% | +87.8M shares |
| Available history | +43% | +53.1M shares |
GLBE has 175M diluted shares, up 3.1% from a year ago, despite $127M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q2 2026 | $68M |
| Q1 2026 | $58.9M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
GLBE spent $127M buying back its own shares over the past year, after none the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
GLBE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -1.0x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2025 | -1.0x | Net Cash |
| Q2 2025 | -1.0x | Net Cash |
| Q1 2025 | -1.2x | Net Cash |
| Q4 2024 | -2.3x | Net Cash |
| Q1 2021 | -3.5x | Net Cash |
GLBE has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
GLBE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.6 | Neutral |
| Stochastic | 67.5 | Neutral |
GLBE's weekly RSI is 57 (neutral) and its Stochastic is 67 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN has the edge over GLBE on valuation relative to its sector.
GLBE PE vs Consumer Cyclical Sector
| Metric | GLBE | Sector median | Relative |
|---|---|---|---|
| PE | 47x | 18x | 163% above |
| PE % | 2 | 53 | 51 pts below |
GLBE is trading at 47x earnings, a 163% premium to the Consumer Cyclical sector's median of 18x.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN is in an uptrend: it's above all five of its weekly moving averages, and 40% above its 200-week average.
GLBE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $40.7 | 0.9% above |
| 20 week MA | $39.7 | 3.5% above |
| 50 week MA | $36.5 | 13% above |
| 100 week MA | $37.7 | 8.9% above |
| 200 week MA | $36.7 | 12% above |
GLBE is in an uptrend: it's above all five of its weekly moving averages, and 12% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over GLBE on returns for 2026, with the stronger performance.
GLBE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $26.8 | $60.9 | +127% |
| 2022 | $60.9 | $19.1 | -69% |
| 2023 | $19.1 | $39.6 | +108% |
| 2024 | $39.6 | $55.0 | +39% |
| 2025 | $55.0 | $39.6 | -28% |
| 2026 YTD | $39.6 | $41.1 | +3.7% |
GLBE's yearly returns have swung widely, from +127% in 2021 to −69% in 2022. It's up 3.7% so far in 2026.